ABSTRACT The objective of this study was to describe the effect on health care utilization and costs of a program of managed care for the Medicaid disabled. The study was designed as a pre/post enrollment cohort comparison and was carried out in three Ohio counties. The subjects were disabled Medicaid-insured patients who voluntarily enrolled in a managed care program for at least 6 months between July 1, 1995 and December 31, 1997, and who had (1) at least one Medicaid claim in the 24-months pre-enrollment period and (2) overall satisfactory postenrollment encounter-level data. Ohio Medicaid provided claims and reimbursements (costs) for the pre-enrollment period and encounter-level data for the postenrollment period. Postenrollment costs were estimated by applying category-specific average pre-enrollment costs to postenrollment utilization data. We measured the following per patient-month: (1) trends in category-specific utilization and costs for up to 24 months before and after enrollment, (2) differences in overall and category-specific costs 1 year before and after enrollment, and (3) changes in the distribution of services 1 year before and after enrollment. Utilization categories included inpatient care, outpatient hospital (including emergency department) care, physician services, prescription medications, durable medical equipment and supplies, and home health care. We found that satisfactory encounter data were available in two of three counties. Of 1,179 enrollees, 592 met all inclusion criteria. Before enrollment, utilization and costs were increasing significantly in four of six categories and were unchanging in two. Postenrollment, decreasing utilization was observed for three categories, one remained unchanged, and two were increasing, but from a lower "baseline." Except for physician services and home health care, there were lower utilization and estimated costs in all categories in the year after enrollment. Estimated inpatient and total costs declined by $155/patient-month (44.9%) and $210/ patient-month (37.1%), respectively. Findings were similar across sites. Inpatient care, outpatient hospital care, and prescription medications accounted for 97% of the reductions in estimated costs in the postenrollment period. Among patients voluntarily enrolled for at least 6 months, managed care for the Medicaid disabled was associated with striking decreases in health care utilization and estimated costs. The effect of managed care on these patients' satisfaction, access to specialized services, quality of care, and health outcomes are understood incompletely.
INTRODUCTION
The dramatic recent increase in programs of managed care for Medicaid patients has occurred within the numerically largest group of beneficiaries, those eligible Given this programmatic variation and paucity of evidence, an assessment of the impact of managed care for these groups is quite difficult, and states have been ambivalent about embarking aggressively in this arena. 2 Consequently, a cautious approach adopted by several states has been to implement managed care for the disabled on a voluntary basis, permitting patients to remain in the fee-for-service sector or to enroll in managed care and to attempt incremental assessments that can guide future program changes, s Two factors make the evaluation of voluntary programs especially challenging. are especially vulnerable to small and biased enrollment. 6 It may be difficult under these circumstances even to establish confident estimates of health care utilization at a meaningful level, such as rates of hospitalization or use of durable medical supplies (wheelchairs, home oxygen, etc.), among relevant subgroups.
It is far more challenging still to judge whether the observed utilization would have been different under a different system of care. Assessments of program impact on quality of care and access to care are similarly, if not even more, complex. Second, because current risk-adjustment systems are limited for predicting the trajectory of future utilization and costs in these populations, 3"7 it is difficult to accurately compare observed with predicted use and costs, another accepted approach to estimating program effect.
Compounding these measurement challenges is the historic absence of reportable encounter-level data from health maintenance organizations, which has been carried forward into the recent era of managed care. Because demographic data were unavailable for noncohort subjects who lacked fee-for-service claims in the pre-enrollment period (N = 52; see Table I ), these patients also were excluded from the comparisons of the cohort subjects with enrollees who were excluded. Similar trend analyses were undertaken for total costs, which were simply the sum of costs associated with claims in all utilization categories.
Effect of managed care on utilization and costs
Second, we computed differences in utilization and costs per patient-month for all eligible cohort patients during the 12 months before and after their enrollment. For these analyses, we used paired t tests and a two-sided hypothesis to test for significance of differences in the number of claims and in costs per patientmonth. We also conducted similar analyses stratified by site and compared differences across sites in claims and costs, including total costs.
Finally, we estimated the effect of managed care on the distribution of utilization of health care services. To do this, we determined the proportion of total measured costs in the pre-enrollment period represented by each category of service (as measured per patient-month), and we compared that proportion with the analogous proportion in the postenrollment period. Although 194 potentially eligible enrollees had no documented postenrollment encounter data, only 37 were excluded solely for this reason. We excluded these 194 patients to avoid reporting a spuriously high decrease in claims following enrollment because of concerns that they could have had unreported encounters during managed care. We nonetheless examined this possibility as well as the alternative explanation that these patients had historically low utilization and therefore plausibly had no encounters during their enrollment in managed care.
Cost analyses and assumptions
To examine these possibilities, we compared the pre-enrollment utilization and costs of enrollees who did (N = 933) or did not (N --194) have postenrollment claims data by category of utilization. In general, as shown in Table 11 , those patients without postenrollment claims had historically low overall utilization in virtually all service categories, whether measured by numbers of claims per month or by the costs associated with those claims. Thus, although it seems quite possible that they had no postenrollment encounters, we elected to exclude them and assume a more conservative analysis.
We next examined the representativeness of our cohort to all enrollees. Table   III compares the pre-enrollment utilization, costs, and demographics of our study cohort (N = 592) with excluded enrollees (N = 535). Although cohort patients appeared to have higher utilization rates and costs associated with pre-enrollment year outpatient hospital care, the cohort otherwise appeared fairly representative of enrollees. The average age of the cohort was 28.2 years (range 0-64 years), 344 (58%) were female, and 331 (56%) were non-white (Table III) . Details of enrollees according to pre-enrollment utilization, cost, and distribution of chronic conditions is described elsewhere. 6 Duration of their enrollment ranged from 6 months for 6% of patients (according to the inclusion criteria for these analyses, none of the cohort was enrolled for less than 6 months), to over 2 years for 12% of patients. Months Before or After Enrollment
Pre/post trends in claims for physician services.
P < .001), physician services (1.9% increase in claims per patient-month, P < .01), drugs (5.0% increase in claims per patient-month, P < .001), and durable medical equipment (0.5% increase in claims per patient-month, P < .001). Analogous increases in costs were observed for these same services. Inpatient hospital and home health care utilization, which had the lowest overall rates of claims of all categories, had slopes that were not significantly different from zero. Months Before or After Enrollment FIGURE 6 Pre/post trends in claims for durable medical equipment. P < .05) and durable medical equipment (0.9% increase in claims per patientmonth, P--.013), although these started at a substantially lower "baseline."
Among the 15 most common prescriptions used both before and after enrollment, examination of NDC revealed no change in the mean number of pills per prescription claim for 13 of 15. Rates of inpatient hospital claims showed no significant change during the postenrollment period. pt-month = patient-month.
DIFFERENCES IN UTILIZATION AND COSTS IN THE YEAR BEFORE AND AFTER ENROLLMENT
claims for physician services. Overall estimated costs decreased by $210 per patient-month or 37.1% (P = .0001).
Table IV also summarizes the distribution of the contributions to total cost differences across categories of service, highlighting the measured services for which reductions had the greatest overall impact on total costs. Collectively, 86%
of pre-enrollment costs were attributable to three categories of service: inpatient care (61%), outpatient hospital care (15%), and prescription medications (10%).
In the year after enrollment, these service categories accounted for 82% of total estimated costs. As shown in Table IV , these three categories of service accounted for 97% of the estimated cost reductions observed after enrollment. reductions--were observed among service categories that were the most costly for these patients in the pre-enrollment period, including inpatient care, outpatient hospital (including emergency department) care, and prescription medications. Proportionately larger reductions were observed in claims and costs for durable medical equipment and supplies, but because the enrollees' pre-enrollment rate of use of these services was relatively low (less than 20 claims per 100 patients monthly), the decrease in costs for these services represented only 5% of the total cost reductions observed after enrollment. Similar effects were observed in claims and costs for home health care services, for which claims were infrequent (approximately 2 per 100 patients monthly) in the year prior to enrollment. Claims for physician services represented slightly less than 10% of the measured pre-enrollment year's Medicaid costs, and in contrast to virtually all other categories, there were no significant changes in these claims during the following year.
Over 75% of the study cohort had at least 2 years of pre-enrollment eligibility and fee-for-service Medicaid claims (Fig. la) , highlighting the relative stability of this population compared with the more numerous, but transient, Medicaid populations supported under ADC/TANF. The stability of the disabled population enabled us to establish reasonably confident estimates of their utilizationrelated trajectories, and our trend analyses (Figs. 2-7 ) present a compelling argument that claims and costs were increasing steadily in the 2 years before enrollment. Further, because "time" in our analysis was relative to enrollment, which occurred gradually during the approximately 2.5 years of this investigation, it seems highly unlikely that the observed changes were due to secular effects. This is especially true for the abrupt changes following enrollment that were observed in claims for prescription medications, durable medical equipment, and home health care services, discussed below.
We have no direct evidence to explain the patterns of changes in utilization;
however, a description of certain elements of the programs and their oversight may be relevant to better understanding. There was a statewide steering committee for this demonstration program; the committee met quarterly to discuss successes and challenges to enrollment and effective program and patient man- were required by the state to implement a case management approach for their enrollees, which in each of the counties was implemented under the guidance of medical codirectors responsible, respectively, for program implementation among children and adult patients. The approach to case management for children at one site is described elsewhere in detail. ~~ Each provider-managed care company pair was required to undertake utilization review procedures, which varied somewhat across sites and over time, but were similar to other contracts within these organizations. In addition, enrollees were required to choose or be assigned a primary care physician who they were expected to visit within 30 days. Formularies were issued to guide physicians' selection of prescription medications, and the choice of pharmacies was limited. New policies permitted physicians to prescribe up to a 3-month (vs. 1-month) supply of medications.
Vendors were selected by the managed care organizations to provide durable medical equipment and home health care services, and referrals to these services required preauthorization by the relevant utilization management authorities.
As described above, there were abrupt decreases after enrollment in claims for prescription medications, durable medical equipment, and home health care.
It is plausible that these abrupt reductions were due to the initiation of new procedures and possible logistical "impediments" in receiving these services under managed care. The significant postenrollment trends toward increasing claims per patient-month for prescription medications and durable medical equipment are consistent with increasing familiarity with these new procedures;
however, these trends also are consistent with an increasing need for these therapeutic supplies among patients with chronic and progressive illnesses. We The second possible source of misestimation is potential under-reporting of claims during managed care. We cannot exclude this possibility, and we did not undertake a comprehensive audit at the medical records level to ascertain the validity and completeness of the claims data submitted to state Medicaid. We offer four types of evidence that lend credence to the data, however. First, the state-level eligibility criteria excluded disabled Medicaid recipients who had dual eligibility for Medicare and those who were eligible for other governmental waiver programs. Thus, it seems unlikely that the lower observed utilization under managed care was due to missed utilization that was paid for by other forms of insurance or governmental aid.
Second, we took steps to minimize the likelihood of including patients in our sample whose claims files might be incomplete. We excluded all enrollees from one county rather than attempt a potentially incomplete reconstruction of encounter-level managed care files from the relevant insurance company's other claims to the state. We also excluded patients who had no claims submitted during managed care, even though that group likely represented a historically lowutilizing subgroup whose apparent inactivity in managed care probably was an accurate reflection of their nonuse of health care services.
Third, we accept as supporting evidence the remarkable similarity in utiliza-tion rates for three important categories of services in the periods just before and after enrollment in managed care. As displayed in Figs. 2-7, claims for inpatient care, outpatient hospital services, and physician services were quite similar in the months immediately before and after enrollment. Since these services were relatively unaffected by utilization review procedures, they would not be expected to change precipitously after enrollment. Further, it would seem quite unlikely that postenrollment use rates, derived from diverse data sources (e.g., physician practice vs. hospital based) submitted over a 2-year interval, would match as closely as they do to fee-for-service Medicaid claims from the pre-enrollment period unless they were accurate.
Fourth, the likeness in cross-site changes in utilization (Table V) , coming as they do from different provider organizations and insurance companies, are similarly improbable as chance occurrences. For the two counties combined, decreases in the "big three" utilization categories accounted for 97% of the estimated cost reductions observed in the year after enrollment--when examined by site, the figures were 97% and 95% for Counties A and B, respectively.
GENERALIZABILITY AND POLICY IMPLICATIONS
Our findings warrant cautious interpretation. The 592 managed care enrollees in our cohort represented a small and comparatively expensive subgroup of Ohio's disabled Medicaid patients who were eligible for enrollment in managed care. In a previous report, 6 we described in detail the differences between those eligible patients who chose to enroll and those who did not. Relative to eligible nonenrollees in their same counties, enrollees had costs for the pre-enrollment year that were 20% higher. To the extent that cost reductions in managed care are proportional to pre-enrollment health care utilization, ~'u the 37% estimated cost reductions observed in the present cohort probably reflect potential "savings" near the upper end of those achievable across the spectrum of disabled Medicaid beneficiaries. In addition, while those eligible for Ohio's managed care program represent the vast majority of Medicaid recipients under its program for the aged, blind, and disabled, expensive and complex institutionalized patients and those with major psychiatric disabilities were excluded specifically from enrollment. Finally, the influence of specific programmatic features (such as steering committee oversight, case management, utilization review and pre-authorization procedures, early physician visits, etc.) is largely unknown, as are the characteristics of the provider organizations, which were large academic health systems with long-standing experience in the care of patients with chronic illnesses and disabilities.
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It also is worthwhile to note that the realization to Medicaid of "potential savings," or to providers of "potential profits," depends also on the ability to spread risk through enrolling a sufficient number of patients to cover unexpected losses, as well as on the accuracy of rate setting and the extent of financial risk sharing between parties. 2~ Similarly, our estimates of cost reductions did not include administrative costs either to Medicaid or to the managed care organizations responsible for program management.
Finally, these analyses do not address other features that are vital to the complete evaluation of this Medicaid managed care program for the disabled.
At the extremes, it is reasonable to question whether these enrollees heavily overutilized in their pre-enrollment period, or alternatively, whether they were underserved seriously under managed care. Although we have reported encouraging findings about patient satisfaction and quality of care from one site, 1~ little is known from other research about the effects of managed care on disabled persons' access to specialized services, their overall quality of care, their health outcomes, or their satisfaction. Until more is known about these other dimensions of effectiveness, both the promise and peril of managed care for this vulnerable population remain great.
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